Phase 1 Crohn's Disease and Colitis Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with moderate-to-severe inflammatory bowel disease (IBD)
- Your IBD has been hard to treat — meaning at least two different types of biologic or small molecule medications have not worked for you, OR you have had at least two bowel surgeries that did not resolve your condition
- Your bone marrow and major organs (such as liver and kidneys) are working well enough to participate
- You are not pregnant and are not planning to become pregnant during the trial
- You are willing to take part in the study
Who may not be able to join:
- You currently have an active infection, a hidden (latent) infection, a serious infection in the last two weeks, or a cancer diagnosis
- You have taken part in another clinical trial within the last four weeks
- You are taking other medications alongside this treatment, except for a low dose of steroid (glucocorticoid)
- You have recently had abdominal surgery or received a live vaccine (confirm with trial site for exact timeframes)
- You have any surgery planned within the next three months
- The trial researchers have determined for any other reason that participation would not be appropriate for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13757118653
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
maximum tolerant dose(MTD); rate of DLT(dose-limiting toxicity)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.